Naphcon-A

Naphazoline/pheniramine

Naphazoline/pheniramine

Combination drug

Naphazoline/pheniramine, sold under the brand name Naphcon-A among others, is a combination eye drop used to help the symptoms of allergic conjunctivitis such as from hay fever.[1] It contains naphazoline and pheniramine.[1][2] It is used as an eye drop.[2] Use is not recommended for more than three days.[3]

Quick Facts Combination of, Pheniramine ...

Side effects may include allergic reactions, eye pain, and dilated pupils.[1][4][3] It is unclear if use in pregnancy is safe.[2] Nephazoline works by resulting in constriction of blood vessels thus decreasing redness while pheniramine works by blocking the effects of histamine to stop itching.[2]

The combination was approved for medical use in the United States in 1994.[5][6][2] It is available over the counter.[5][6][1] In 2017, it was the 203rd most commonly prescribed medication in the United States, with more than two million prescriptions.[7][6]

Medical use

It is administered topically with one to two drops applied to the affected eye(s) up to four times daily.[1]

Adverse effects

References

  1. [1]
    "Naphcon A- naphazoline hydrochloride and pheniramine maleate solution/ drops". DailyMed. 16 September 2019. Retrieved 10 August 2020.
  2. [2]
    "Naphazoline and pheniramine ophthalmic Uses, Side Effects & Warnings". Drugs.com. Retrieved 19 April 2019.
  3. [3]
    Kizior RJ, Hodgson BB (2014). Saunders Nursing Drug Handbook 2015 - E-Book. Elsevier Health Sciences. p. 163. ISBN 9780323280181.
  4. [4]
    "Naphazoline/pheniramine ophthalmic Side Effects in Detail". Drugs.com. Retrieved 19 April 2019.
  5. [5]
    "Naphcon-A: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 19 April 2020.
  6. [6]
    "Naphazoline Hydrochloride; Pheniramine Maleate - Drug Usage Statistics". ClinCalc. Retrieved 11 April 2020.
  7. [7]
    "The Top 300 of 2020". ClinCalc. Retrieved 11 April 2020.
Share this article:

This article uses material from the Wikipedia article Naphcon-A, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.